Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
gene therapy
3
×
glaxosmithkline
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amicus therapeutics
biogen
biotech
celgene
crispr
crispr therapeutics
fda
gene editing
gilead sciences
medicare
messenger rna
novartis
What
bio
crispr
3
×
roundup
new
acquisitions
albert
allogene
biggest
biopharma
bourla
cancer
ceo
company
congress
congressional
diversity
drug
executives
feud
future
group
hot
immunotherapy
imports
investors
ipo
isn’t
juno
known
later
maker
maps
measured
million
month
nearly
ny
patients
pfizer
pfizer’s
Language
unknown
Current search:
crispr
×
glaxosmithkline
×
" gene therapy "
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More